Safety and Efficacy Study of Ad2/Hypoxia Inducible Factor (HIF)-1α/VP16 Gene Transfer in Patients With Intermittent Claudication
Clinical trial NCT00117650 · COMPLETED
Trial details
- NCT number
- NCT00117650
- Sponsor
- Genzyme, a Sanofi Company
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2005-02-01
- Primary completion
- 2008-09-01
- Enrollment
- 289
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.